Multiple Sclerosis and Pregnancy: Every Stage Explained by an MS Specialist

One of the first questions after a multiple sclerosis diagnosis, sometimes before anything else, is whether children are still possible. They are. Most women with MS have healthy pregnancies and healthy babies, and pregnancy does not make MS worse in the long run. What MS asks for is planning: about medication, about timing, and about the months after delivery.

This guide walks through every stage in order, from fertility and conception to breastfeeding and restarting treatment, and answers the questions that come up most often along the way.

Can women with MS have children?

Yes. MS has no direct effect on fertility. Women with MS conceive at the same rate as women without it, and the disease does not increase the risk of miscarriage, birth defects, premature birth, or low birth weight when medications are managed appropriately.

A few practical points are worth knowing.

• Some MS medications can harm a developing baby, which is the main reason planning comes first. This is about the drug, not the disease.
• MS symptoms can get in the way of conceiving without affecting fertility itself. Fatigue, spasticity, bladder symptoms, and sexual dysfunction are all manageable, and worth raising with your care team rather than working around silently.
• Fertility treatment is an option. IVF and other assisted reproduction techniques are safe for women with MS. Older studies found a clear rise in relapse risk in the months after IVF, mainly with one type of hormone protocol (GnRH agonists) and when a cycle did not lead to pregnancy. Newer protocols that use GnRH antagonists appear safer. Either way, it is best coordinated between your neurologist and your fertility specialist.
• Men with MS can father children, and most MS medications taken by men do not require special precautions, though a few do. Ask your neurologist.

How pregnancy affects MS

Pregnancy is one of the most reliably protective states in MS. As the immune system shifts to tolerate the developing baby, the autoimmune activity that drives neuroinflammation quiets down too. Relapse rates fall through the first and second trimesters and, in the third trimester, are roughly 70 percent lower than in the year before pregnancy. Relapses that do occur during pregnancy tend to be milder than usual.

The picture changes after delivery. In the first three months after delivery the relapse rate rises above the pre-pregnancy level. In the original long-term study, about 28 percent of women, a little more than one in four, had a relapse in that window. Women with active MS in the year before pregnancy, and those who were not on treatment before conceiving, are at the higher end of that risk. This is the single most important reason to decide, before the baby arrives, how and when treatment will restart. After that early window the relapse rate returns to its usual baseline, and pregnancy does not accelerate long-term disability. Some studies suggest women who have been pregnant do slightly better over decades, not worse. Having more than one child is safe with the same planning each time.

Here is the whole journey at a glance.

Planning a pregnancy with MS: a step-by-step checklist

Most of what makes a pregnancy go well with MS happens before it starts. This is the sequence used in preconception planning.

1. Talk to your neurologist before you start trying. Ideally this conversation happens six to twelve months ahead, because some medication changes need lead time. Bring your obstetrician into the loop early too.
2. Get your MS stable first. Women whose MS was active in the year before pregnancy have more postpartum relapses. The aim is no recent relapses, a stable examination, and a stable MRI before conception. The neurofilament light chain blood test can add reassurance that inflammation is quiet before medication is adjusted.
3. Make a medication plan for the specific drug you take. The principles are in the next section. The details, including timing, are individual and are worked out with your MS specialist.
4. Get a baseline MRI. A scan before conception gives a reference point if questions arise during or after pregnancy, when contrast is avoided. Our guide to understanding your MS brain MRI explains what it shows.
5. Look after the basics. Start a prenatal vitamin with folic acid, have your vitamin D level checked and corrected if low, stop smoking, and keep moving. Our guide to lifestyle changes for brain health in MS covers what helps.
6. Sort out symptom medications. Drugs for spasticity, bladder symptoms, pain, fatigue, or mood each need their own review; some are fine in pregnancy and others are not.
7. Decide the postpartum plan in advance. When treatment restarts, which medication, and whether you plan to breastfeed. Making these decisions in the third trimester, not after a sleepless first month at home, is what prevents the delay that leads to postpartum relapses.

Plan for pregnancy and the months after

• Start early: Discuss family plans with your neurologist and obstetrician.
• Review each medication: Timing and changes depend on the specific treatment you take.
• Plan postpartum care: Agree on treatment restart and feeding plans before the baby arrives.

MS medications and pregnancy: the principles

No disease-modifying therapy is formally approved for use during pregnancy, but decades of pregnancy registries and real-world data now guide decisions. Broadly, MS medications fall into three groups. Find yours here; the details follow the table.

Medications that can be continued until pregnancy is confirmed, and sometimes through it. Glatiramer acetate has the longest safety record in pregnancy; it is a large molecule that does not readily cross the placenta. Interferon beta has a similarly reassuring record. For women with very active MS, some specialists continue certain other therapies into pregnancy after weighing the risk of relapse against the risk of exposure.

Medications that are stopped shortly before trying to conceive. The fumarates, such as dimethyl fumarate and diroximel fumarate, clear the body quickly, so they can be continued until close to the time of conception and stopped without a long gap.

Medications that need a long lead time, a planned transition, or both. Teriflunomide can persist in the body for a very long time and requires a specific elimination procedure before pregnancy is safe. The S1P modulators such as fingolimod must be stopped well ahead of conception and carry a risk of rebound disease activity if stopped without a plan, so the transition is managed carefully. The anti-CD20 therapies sit in a category of their own: their protective effect on MS outlasts the drug in the body, so the last dose is timed to allow the medication to clear before conception while B-cell suppression continues to protect against relapses through much of the pregnancy. Registry data so far have been reassuring, and the timing is set individually.

Two rules apply across all of them. Do not stop or change a disease-modifying therapy on your own, because for some drugs stopping abruptly is riskier than the drug itself. And if you become pregnant unexpectedly while on treatment, call your neurologist that week rather than stopping and waiting: for most medications the right step is a planned one, and the reassuring registry data mean that an unplanned exposure is usually not the emergency it feels like.

During pregnancy

For most women with MS, pregnancy care is the same as for anyone else. A few MS-specific points apply.

• Check-ins. Most neurologists see pregnant patients with MS about once per trimester, more often if there are concerns. These visits are easily done by video.
• MRI. MRI without contrast is considered safe in pregnancy and is done if there is a clinical reason. Gadolinium contrast crosses the placenta and is avoided.
• Symptoms that overlap. Fatigue, urinary frequency, back pain, and balance changes are part of many normal pregnancies and also part of MS. New neurological symptoms, meaning something you have not had before, or a clear step down in function, should be reported rather than assumed to be pregnancy.

Treatment of an MS relapse in pregnancy

Relapses during pregnancy are uncommon, especially in the second and third trimesters, but they can happen. If new neurological symptoms last more than a day, contact your neurologist, who will first check for an infection or other trigger that can mimic a relapse. A sudden severe headache, sudden weakness or vision loss, or a seizure during pregnancy or after delivery is an emergency: call 911. Mild relapses are often observed without treatment. For a relapse that is affecting function, a short course of corticosteroids can be used, generally avoided in the first trimester when possible and considered safe later in pregnancy, with the form and length chosen by your neurologist in discussion with your obstetrician. For a severe relapse that does not respond, plasma exchange is an option that can be used in pregnancy. Our guide to what to do during an MS relapse covers how to recognize one.

Delivery and anesthesia

MS does not dictate how you deliver. Vaginal birth and cesarean section are both safe, and the decision is made on obstetric grounds. Epidural and spinal anesthesia are safe in MS; the belief that they trigger relapses is a persistent myth not supported by evidence. Tell your obstetric and anesthesia team about your MS, particularly if you have significant weakness, spasticity, or fatigue, so they can plan positioning and support during labor.

After the baby arrives

Restarting treatment

The plan made in the third trimester goes into effect after delivery. For many women that means restarting a disease-modifying therapy soon after birth. The choice of medication and the timing depend on how active your MS has been and on whether you are breastfeeding.

Breastfeeding

Breastfeeding is a personal decision, and it is compatible with good MS care whichever way you choose. Two facts help.

Exclusive breastfeeding, with no formula, for at least the first two months has been associated with a lower risk of postpartum relapse in several studies. It is not a guarantee, and it is not a substitute for treatment in women with active MS.

Several MS medications can be used while breastfeeding. Glatiramer acetate, interferon beta, and some monoclonal antibodies are large molecules that pass into breast milk in very small amounts, and specialists increasingly support their use in nursing mothers. Most oral medications are not recommended while breastfeeding. Which category your medication falls into is a conversation to have before delivery, so that the choice between breastfeeding and restarting a particular drug is never made under pressure. Sleep deprivation, a known trigger for symptom flares, is worth planning for as well: enlist help for nights where you can.

Prepare support for after delivery

• Restart plan: Follow the individualized treatment plan made before delivery.
• Feeding decisions: Discuss medication compatibility and your preferences in advance.
• Practical support: Arrange help where possible, including support for disrupted sleep.

When to talk to your MS specialist

Reach out if you are thinking about pregnancy in the coming year, if you have just found out you are pregnant while on MS medication, if you have new neurological symptoms during pregnancy or after delivery, if you want help weighing breastfeeding against restarting treatment, or if you would like a second opinion on a plan you have been given. Can MS and a family fit together? Most women with MS have healthy pregnancies and healthy babies, with planning. In a 60-minute first visit for a multiple sclerosis evaluation, Dr. Achillefs Ntranos works out the medication timeline, monitoring plan, and postpartum plan with you, so no decision is made under pressure. Follow-ups are usually every one to three months and last 30 to 45 minutes. Request a visit in Beverly Hills or Los Angeles, or by video anywhere in California. No referral is needed, and the office confirms within 1 business day.

References

1. Confavreux C, et al. Rate of pregnancy-related relapse in multiple sclerosis (PRIMS). New England Journal of Medicine, 1998.
2. Cleveland Clinic Mellen Center. Management of multiple sclerosis during pregnancy.
3. MS Trust. Pregnancy and MS.
4. Patient-centered pregnancy planning in multiple sclerosis: evidence for a new era. 2024.
5. Johns Hopkins Medicine. Multiple sclerosis and pregnancy.
6. Michel L, et al. Increased risk of multiple sclerosis relapse after in vitro fertilisation. Journal of Neurology, Neurosurgery and Psychiatry, 2012.
7. Bove R, et al. Effect of assisted reproductive technology on multiple sclerosis relapses: case series and meta-analysis. Multiple Sclerosis Journal, 2019.
8. MS Trust. Risk of developing MS.
9. NeurologyLive. Breastfeeding protects against postpartum relapse in MS: meta-analysis findings.
10. Shakeri A, et al. Safety of neuraxial anesthesia in patients with multiple sclerosis: a systematic review of observational evidence. Multiple Sclerosis and Related Disorders, 2025.